---
title: "Metirosine - Pheochromocytoma"
sidebar: mydoc_sidebar
permalink: db00765-mesh-d010673-1.html
toc: false 
---


Path ID: `DB00765_MESH_D010673_1`
{% include image.html url="images/db00765-mesh-d010673-1.png" file="db00765-mesh-d010673-1.png" alt="db00765-mesh-d010673-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D019805">MESH:D019805 </a> | metirosine | Drug |
| <a href="https://identifiers.org/UniProt:P07101">UniProt:P07101 </a> | Tyrosine 3-monooxygenase | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-209905">reactome:R-HSA-209905 </a> | Catecholamine biosynthesis | Pathway |
| <a href="https://identifiers.org/CHEBI:18243">CHEBI:18243 </a> | Dopamine | ChemicalSubstance |
| <a href="https://identifiers.org/CHEBI:33568">CHEBI:33568 </a> | adrenaline | ChemicalSubstance |
| <a href="https://identifiers.org/CHEBI:33569">CHEBI:33569 </a> | noradrenaline | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | Vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/HP:0000822">HP:0000822 </a> | Hypertension | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D010673">MESH:D010673 </a> | Pheochromocytoma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Metirosine | DECREASES ACTIVITY OF | Tyrosine 3-Monooxygenase |
| Tyrosine 3-Monooxygenase | POSITIVELY REGULATES | Catecholamine Biosynthesis |
| Catecholamine Biosynthesis | POSITIVELY CORRELATED WITH | Dopamine |
| Catecholamine Biosynthesis | POSITIVELY CORRELATED WITH | Adrenaline |
| Catecholamine Biosynthesis | POSITIVELY CORRELATED WITH | Noradrenaline |
| Dopamine | POSITIVELY REGULATES | Vasoconstriction |
| Adrenaline | POSITIVELY REGULATES | Vasoconstriction |
| Noradrenaline | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | AFFECTS RISK FOR | Hypertension |
| Hypertension | MANIFESTATION OF | Pheochromocytoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00765](https://go.drugbank.com/drugs/DB00765)
  - [https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1200862](https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1200862)
  - [https://en.wikipedia.org/wiki/Pheochromocytoma](https://en.wikipedia.org/wiki/Pheochromocytoma)
  - [https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=441350](https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=441350)
